Macular Degeneration Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with age-related macular degeneration (a condition affecting central vision) and are aged 60 or older, or people who have been diagnosed with juvenile macular degeneration and are currently aged 18 or older.
- People whose vision in their better eye falls within a specific range — not too strong and not too weak — roughly between mild and moderate vision loss (confirm with trial site for exact measurements).
- People whose reading vision in their better eye meets a minimum standard when tested at 40 cm distance (confirm with trial site for exact measurements).
- People whose vision has been stable for the past 3 months, based on their own report.
- People who have loss of central vision.
Who may not be able to join:
- People who have been diagnosed with dementia.
- People who are not able to read fluently in English (for the Waterloo site) or Chinese characters (for the Hong Kong site).
- People who have had eye surgery or injections into the eye during the study period, unless: the injections have been ongoing continuously for at least 1 year; or the injections stopped at least 2 months before joining; or the injections were only in the eye that is not being tested.
- People who have another eye condition — beyond macular degeneration — that could significantly reduce central vision (for example, a more advanced cataract may be a concern, while a mild cataract may be acceptable).
- People with severe hearing impairment.
- People who have medical reasons that would make brain stimulation unsafe for them (confirm with trial site for details).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ben Thompson, PhD, University of Waterloo
Phone: 15198884567
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in Rapid Serial Visual Presentation (RSVP) Reading performance before and right after training.; Change in Rapid Serial Visual Presentation (RSVP) Reading performance 30 days after training
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.